| scholarly article | Q13442814 |
| P2093 | author name string | Yoko Takahashi | |
| Mitsuhiro Tada | |||
| Tetsuya Moriuchi | |||
| Masaki Miyamoto | |||
| Satoshi Kondo | |||
| Osamu Takahashi | |||
| Toshiaki Morikawa | |||
| Motoki Abe | |||
| Jun-Ichi Hamada | |||
| P433 | issue | 4 | |
| P304 | page(s) | 797-802 | |
| P577 | publication date | 2006-04-01 | |
| P1433 | published in | Oncology Reports | Q7092098 |
| P1476 | title | Disordered expression of HOX genes in human non-small cell lung cancer. | |
| P478 | volume | 15 |
| Q35190545 | A functional in vivo screen for regulators of tumor progression identifies HOXB2 as a regulator of tumor growth in breast cancer |
| Q24569826 | ALDH isozymes downregulation affects cell growth, cell motility and gene expression in lung cancer cells |
| Q42238571 | Abnormal gene expression and gene fusion in lung adenocarcinoma with high-throughput RNA sequencing |
| Q34066447 | An E2F1-HOXB9 transcriptional circuit is associated with breast cancer progression |
| Q64086430 | Clinical significance of long non-coding RNA HOTTIP in early-stage non-small-cell lung cancer |
| Q92351012 | Deciphering The Potential Role of Hox Genes in Pancreatic Cancer |
| Q36485786 | Elevated HOXA1 expression correlates with accelerated tumor cell proliferation and poor prognosis in gastric cancer partly via cyclin D1 |
| Q37419612 | Epigenetic silencing of the RASSF1A tumor suppressor gene through HOXB3-mediated induction of DNMT3B expression |
| Q91975269 | Expression Profile and Prognostic Values of HOXA Family Members in Laryngeal Squamous Cell Cancer |
| Q92646622 | Expression and clinical significance of HOXA5, E-cadherin, and β-catenin in cervical squamous cell carcinoma |
| Q37327550 | Gene identification for risk of relapse in stage I lung adenocarcinoma patients: a combined methodology of gene expression profiling and computational gene network analysis |
| Q36402751 | Genome-wide aberrant DNA methylation of microRNA host genes in hepatocellular carcinoma |
| Q34427951 | HOX genes and their role in the development of human cancers. |
| Q39893026 | HOX transcription factors are potential therapeutic targets in non-small-cell lung cancer (targeting HOX genes in lung cancer). |
| Q37228895 | HOXA1 binds RBCK1/HOIL-1 and TRAF2 and modulates the TNF/NF-κB pathway in a transcription-independent manner |
| Q92799098 | HOXA10 knockdown inhibits proliferation, induces cell cycle arrest and apoptosis in hepatocellular carcinoma cells through HDAC1 |
| Q52716394 | HOXA4, down-regulated in lung cancer, inhibits the growth, motility and invasion of lung cancer cells. |
| Q33702367 | HOXA5 and p53 cooperate to suppress lung cancer cell invasion and serve as good prognostic factors in non-small cell lung cancer. |
| Q38924388 | HOXA5 indicates poor prognosis and suppresses cell proliferation by regulating p21 expression in non small cell lung cancer |
| Q35413993 | HOXA5 inhibits metastasis via regulating cytoskeletal remodelling and associates with prolonged survival in non-small-cell lung carcinoma |
| Q33276506 | HOXA7, HOXA9, and HOXA10 are differentially expressed in clival and sacral chordomas |
| Q49299856 | HOXC10 up-regulation promotes gastric cancer cell proliferation and metastasis through MAPK pathway |
| Q33597261 | Influence of Hoxa5 on p53 tumorigenic outcome in mice |
| Q35805617 | Integrated analysis of DNA methylation and microRNA regulation of the lung adenocarcinoma transcriptome |
| Q39702877 | MicroRNA miR-196a is a central regulator of HOX-B7 and BMP4 expression in malignant melanoma |
| Q42315789 | MicroRNA-30e reduces cell growth and enhances drug sensitivity to gefitinib in lung carcinoma |
| Q36544957 | MicroRNA-99a inhibits tumor aggressive phenotypes through regulating HOXA1 in breast cancer cells |
| Q35156742 | Novel candidate key drivers in the integrative network of genes, microRNAs, methylations, and copy number variations in squamous cell lung carcinoma. |
| Q58096309 | Over-expressed lncRNA HOTAIRM1 promotes tumor growth and invasion through up-regulating HOXA1 and sequestering G9a/EZH2/Dnmts away from the HOXA1 gene in glioblastoma multiforme |
| Q35007734 | Picoplatin overcomes resistance to cell toxicity in small-cell lung cancer cells previously treated with cisplatin and carboplatin |
| Q24312173 | Proinvasion metastasis drivers in early-stage melanoma are oncogenes |
| Q34395225 | Silencing HoxA1 by intraductal injection of siRNA lipidoid nanoparticles prevents mammary tumor progression in mice |
| Q92847368 | Silencing of LINC00461 enhances radiosensitivity of lung adenocarcinoma cells by down-regulating HOXA10 via microRNA-195 |
| Q33539413 | Targeting HOX and PBX transcription factors in ovarian cancer |
| Q37722452 | The Hox genes and their roles in oncogenesis. |
| Q38976675 | The roles of HOXD10 in the development and progression of head and neck squamous cell carcinoma (HNSCC). |
| Q39900581 | The truncated Hoxa1 protein interacts with Hoxa1 and Pbx1 in stem cells |
| Q52586740 | Upregulation of HOXA1 promotes tumorigenesis and development of non‑small cell lung cancer: A comprehensive investigation based on reverse transcription-quantitative polymerase chain reaction and bioinformatics analysis. |
| Q37182096 | miEAA: microRNA enrichment analysis and annotation |
| Q64094883 | promotes migration, invasion and proliferation of esophageal squamous cell carcinoma cells via modulating expression of genes involved in malignant phenotypes |
Search more.